Trials / Unknown
UnknownNCT04928365
Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy
Open Prospective Clinical Trial to Develop the Computer Software (Intelligent Prognostic System) for Predicting the Efficacy of Anti-PD-1 Immunotherapy of Melanoma Patients in Routine Practice
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Blokhin's Russian Cancer Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Open prospective clinical trial to develop the computer software (Intelligent prognostic system) for predicting the efficacy of anti-PD-1 immunotherapy of melanoma patients in routine practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-PD-1 monoclonal antibody | Anti-PD-1 therapy |
Timeline
- Start date
- 2021-03-25
- Primary completion
- 2021-05-11
- Completion
- 2023-03-25
- First posted
- 2021-06-16
- Last updated
- 2021-06-16
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04928365. Inclusion in this directory is not an endorsement.